Clinical Trial Update: Optimisation of Antipsychotic Drug Use in Older People [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on optimizing antipsychotic use in older people with Alzheimer's disease or schizophrenia; the study has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Schizophrenia

Snippet

Sponsor: Institute of Psychiatry, London | Conditions: Alzheimer's Disease, Schizophrenia | Phase 4 | Status: TERMINATED